Im, S., Alonso, G., Moreno, I., Rohrberg, K. S., Gambardella, V., Italiano, A., Lim, S., Cheeti, S., Yu, P., Swat, A., Amair-Pinedo, F., Juric, D. (2025). Phase Ib study of inavolisib (INAVO) + weekly paclitaxel (wP) in patients (pts) with locally advanced/metastatic (LA/m) incurable solid tumors: Safety, pharmacokinetics (PK), and preliminary antitumor activity.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1062